Commonly Prescribed Acid Reflux Medication Not Helpful for Children With Asthma
Published Online: Friday, July 20, 2012
Acid reflux is common among children with asthma, and in recent years there has been a dramatic increase in prescriptions of proton pump inhibitors (PPIs) for children with asthma. This episode of the JAMA Report discusses a controlled study in which pediatric asthma patients without acid reflux symptoms were given either placebo or a PPI in addition to corticosteroids. The study found that PPI treatment did not improve asthma symptoms and may come with risks, including increased chance of infection.
From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.